DiscoveRx Corporation Announces the Expansion of KINOMEscan’s Largest Commercially Available Kinase Panel
Published: Jun 02, 2011
DiscoveRx announced today the successful expansion of its industry leading KINOMEscan™ kinase assay panel for kinase inhibitor profiling and screening services. Now with 451 kinase assays in the scanMAX™ assay panel, which will be available for global customers by mid-June 2011, DiscoveRx continues to maintain its leadership position by offering the largest validated kinase panel for screening and profiling services. This milestone achievement reaffirms DiscoveRx’s continued commitment to invest in developing innovative new products and solutions for the drug discovery community.